SCHEMBL4186605

SCHEMBL4186605

CC(CC1CCCCC1)NCc1ccccc1NS(=O)(=O)c1cc2cc(Cl)ccc2s1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.41
POLB P06746 1/20 0.41
GHSR Q92847 2/20 0.41
HTR1A P08908 1/20 0.38
DRD2 P14416 1/20 0.38
HTR2A P28223 1/20 0.38
F10 P00742 5/20 0.38
KDM4E B2RXH2 1/20 0.38
PKM P14618 1/20 0.38
ALDH1A1 P00352 2/20 0.36
CCR2 P41597 3/20 0.36
KIT P10721 1/20 0.34
CCR1 P32246 2/20 0.33
CCR4 P51679 2/20 0.33
ATM Q13315 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
PI4KB Q9UBF8 1/20 0.32
PYGL P06737 1/20 0.32
MAPT P10636 1/20 0.32
HTT P42858 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4190584 0.99 GHSR (0.41) LMNAPOLBGHSRHTR1ADRD2
SCHEMBL4197675 0.90 CCR2 (0.41) LMNAPOLBGHSRHTR1ADRD2
SCHEMBL4200095 0.90 CCR2 (0.41) LMNAPOLBGHSRHTR1ADRD2
SCHEMBL4195304 0.90 CCR2 (0.41) LMNAPOLBGHSRHTR1ADRD2
SCHEMBL4192467 0.90 KDM4E (0.38) LMNAPOLBGHSRHTR1ADRD2
SCHEMBL4197433 0.90 KDM4E (0.38) LMNAPOLBGHSRHTR1ADRD2
SCHEMBL4192385 0.89 CCR2 (0.41) LMNAPOLBGHSRHTR1ADRD2
SCHEMBL4198286 0.89 KDM4E (0.36) LMNAPOLBGHSRHTR1ADRD2
SCHEMBL4190303 0.89 CA2 (0.37) LMNAPOLBGHSRHTR1ADRD2
SCHEMBL4202537 0.87 HTR1A (0.41) POLBGHSRHTR1ADRD2HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1879877-B1 ANTIMICROBIAL AGENTS RANBAXY LAB LTD (IN) 2013-01-02 EP claimed
US-8076370-B2 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2011-12-13 US claimed
US-20090215764-A1 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2009-08-27 US claimed
EP-1879877-B1 ANTIMICROBIAL AGENTS RANBAXY LAB LTD (IN) 2013-01-02 EP disclosed
US-8076370-B2 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2011-12-13 US disclosed
US-20090215764-A1 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2009-08-27 US disclosed
EP-1879877-A2 ANTIMICROBIAL AGENTS Ranbaxy Laboratories Limited (IN) 2008-01-23 EP disclosed
WO-2006117762-A2 ANTIMICROBIAL AGENTS RANBAXY LABORATORIES LIMITED (IN) 2006-11-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215764-A1 Antimicrobial agents TUFM, RPS17, HARS1 LMNA 2332/4885POLB 215/4885GHSR 3645/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.